Bevacizumab/temozolomideLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1974卷 / 1期

关键词：

D O I：

10.1007/s40278-023-46091-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：80 / 80

相关论文

共 50 条

[31] TemozolomideLack of efficacy: case report
Reactions Weekly, 2022, 1933 (1) : 392 - 392
[32] TemozolomideLack of efficacy: case report
Reactions Weekly, 2024, 2025 (1) : 433 - 433
[33] TemozolomideLack of efficacy: case report
Reactions Weekly, 2023, 1960 (1) : 401 - 401
[34] TemozolomideLack of efficacy: case report
Reactions Weekly, 2025, 2040 (1) : 933 - 933
[35] TemozolomideLack of efficacy: case report
Reactions Weekly, 2022, 1936 (1) : 454 - 454
[36] TemozolomideLack of efficacy: case report
Reactions Weekly, 2022, 1929 (1) : 597 - 597
[37] TemozolomideLack of efficacy: case report
Reactions Weekly, 2021, 1867 (1) : 377 - 377
[38] Bevacizumab/irinotecan/temozolomideLack of efficacy: 6 case reports
Reactions Weekly, 2024, 2024 (1) : 92 - 92
[39] Bevacizumab/lomustine/temozolomideLack of efficacy: 3 case reports
Reactions Weekly, 2022, 1918 (1) : 105 - 105
[40] Bevacizumab/talaporfin/temozolomideLack of efficacy
Reactions Weekly, 2024, 2004 (1) : 90 - 90

← 1 2 3 4 5 →